Literature DB >> 7564473

Megakaryocytes and fibroblasts--interactions as determined in normal human bone marrow specimens.

B Schmitz1, J Thiele, R Kaufmann, O Witte, C Wickenhauser, F Kuhn-Regnier, R Fischer.   

Abstract

An in vitro study was performed to investigate possible interactions between megakaryocytes and bone marrow fibroblasts, both obtained from healthy donors. We were able to demonstrate that the proliferation of fibroblasts increased significantly by co-culturing these cells with megakaryocytes for 6 days. Addition of neutralizing antibodies for PDGF and TGF beta 1, caused a significant reduction of fibroblast growth. Inhibition of cell to cell contacts via tissue culture inserts generated a conspicuous impairment of fibroblast proliferation compared with megakaryocyte-fibroblast co-cultures, where contact was allowed. Hence, our findings suggest that a close spatial relationship between megakaryocytes and fibroblasts is needed for the activation of growth in normal human bone marrow. Neighbouring of megakaryocytes and fibroblasts seems to be necessary in order to achieve a certain threshold of local growth factor concentration. Our results are in keeping with the assumption that PDGF and TGF beta 1, are secreted by normal human megakaryocytes in very low concentrations and promote significantly fibroblast proliferation.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7564473     DOI: 10.1016/0145-2126(95)00035-m

Source DB:  PubMed          Journal:  Leuk Res        ISSN: 0145-2126            Impact factor:   3.156


  2 in total

1.  Enhanced growth of canine bone marrow stromal cell cultures in the presence of acidic fibroblast growth factor and heparin.

Authors:  S Emami; W Merrill; V Cherington; G G Chiang; M Kirchgesser; J M Appel; M Hansen; P H Levine; J S Greenberger; D R Hurwitz
Journal:  In Vitro Cell Dev Biol Anim       Date:  1997 Jul-Aug       Impact factor: 2.416

Review 2.  Integrins and their role in megakaryocyte development and function.

Authors:  Xiaosheng Yang; Shlok V Chitalia; Shinobu Matsuura; Katya Ravid
Journal:  Exp Hematol       Date:  2021-12-12       Impact factor: 3.249

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.